Ilika plc (LON:IKA) has delivered its first batch of commercial-grade Stereax cathodes to Cirtec Medical, turning a January purchase order into tangible production progress. CEO Graeme Purdy explains why keeping cathode manufacturing in the UK is central to the strategy, how the supply pipeline to Cirtec will now begin a steady cadence, and where the Stereax M300 is gaining traction across next-generation implantable medical devices.

Key Moments

• 00:11 – Interview introduction – Graeme Purdy joins to discuss delivery of commercial-grade Stereax electrodes to Cirtec Medical for Stereax M300 production.
• 00:22 – What’s new in the announcement – Ilika confirms it has delivered the first batch of commercial-grade electrodes, fulfilling the initial purchase order.
• 01:03 – Role of the cathode – Explanation of how the cathode stores lithium in a solid-state battery and moves ions during charging.
• 01:43 – Why production is split UK and US – Cathode manufacturing remains in the UK as the most complex step, helping ensure a smooth technology transfer to Cirtec.
• 02:29 – Key applications for Stereax M300 – Implantable sensors, smart orthopaedics, neurostimulators, orthodontics and ophthalmology devices.
• 03:59 – Commercial-grade batteries entering testing and prototypes – Some units entering extended testing while others support early product integration.
• 04:37 – Regular supply expected – A “drumbeat” of electrode supply planned as production ramps through this year and next.

Ilika Plc is a pioneer in solid state battery technology, enabling solutions for applications such as Industrial IoT, MedTech, Electric Vehicals and Consumer Electronics.